Approval · Notice of Compliance 3858 · 1997
CEREZYME: Notice of Compliance 3858
Issued February 12, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3858
- Date
- February 12, 1997
- Company
- Genzyme CorporationCambridge, Massachusetts, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEREZYME | 02230694 | Cancelled Post Market |
Medicinal ingredients
- IMIGLUCERASE 200 UNIT per VIAL